J Clin Outcomes Manage
2007 May ;14(5):275-293
Diabetic nephropathy for the primary care physician: more than microalbuminuria
Giullian JA, Chuang P, Lewis JB
Program Audience Primary care physicians Educational Needs Addressed Diabetic nephropathy affects 25% to 40% of patients with diabetes. It is a significant contributor to the morbidity, mortality, and health care costs among patients with diabetes and is the leading cause of end-stage renal disease in the United States. Prevention and slowing progression are the most important aspects of the management of diabetic nephropathy. This involves monitoring renal function and risk factors for renal damage and early active intervention. Studies have shown that primary care physician adherence to diabetes guidelines is suboptimal. Employing strategies that support the achievement of clinical targets recommended by evidence-based guidelines is of paramount importance. Educational Objectives After participating in this CME activity, primary care physicians should be able to 1. Identify early diabetic nephropathy 2. Describe the pathophysiology of diabetic nephropathy 3. Discuss key measures known to reduce risk and progression of diabetic nephropathy 4. State the drug therapy of choice for treatment of diabetic nephropathy
Case-Based Review, CME
Search the Turner White index to find abstracts of articles published in JCOM.